| Harbor Grace Hospice, Inc 500 Lanier Avenue West, Suite 401, Fayetteville, GA, 30214 | |
| (678) 962-5850 |
News Archive
Orchard Therapeutics, a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the opening of a second facility for technical operations in the San Francisco Bay Area.
The Federation of State Medical Boards approved a model telehealth policy this weekend that's made some providers of these services happy and others, well, not so much, because of its emphasis on using video rather than audio technology for a first patient visit (Conn, 4/28).
The world's leading mass spectrometer manufacturers have agreed to license technology that enabled University of Southern California (USC) researchers to develop software that, for the first time, allows scientists to easily use and share research data collected across proprietary platforms.
The UK is shouldering the brunt of economic burden from coronary heart disease, according to new pan-European statistics from the British Heart Foundation and the European Heart Network.
Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.
› Verified 5 days ago
| Name | Harbor Grace Hospice, Inc |
|---|---|
| Location | 500 Lanier Avenue West, Suite 401, Fayetteville, Georgia |
| Hospice ID | 111621 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 451 |
News Archive
Orchard Therapeutics, a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the opening of a second facility for technical operations in the San Francisco Bay Area.
The Federation of State Medical Boards approved a model telehealth policy this weekend that's made some providers of these services happy and others, well, not so much, because of its emphasis on using video rather than audio technology for a first patient visit (Conn, 4/28).
The world's leading mass spectrometer manufacturers have agreed to license technology that enabled University of Southern California (USC) researchers to develop software that, for the first time, allows scientists to easily use and share research data collected across proprietary platforms.
The UK is shouldering the brunt of economic burden from coronary heart disease, according to new pan-European statistics from the British Heart Foundation and the European Heart Network.
Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.
› Verified 5 days ago
| NPI Number | 1205960473 |
| Organization Name | Harbor Grace Hospice, Inc. |
| Address | 500 W Lanier Ave Fayetteville, Georgia, 30214 |
| Phone Number | (678)962-5850 |
News Archive
Orchard Therapeutics, a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the opening of a second facility for technical operations in the San Francisco Bay Area.
The Federation of State Medical Boards approved a model telehealth policy this weekend that's made some providers of these services happy and others, well, not so much, because of its emphasis on using video rather than audio technology for a first patient visit (Conn, 4/28).
The world's leading mass spectrometer manufacturers have agreed to license technology that enabled University of Southern California (USC) researchers to develop software that, for the first time, allows scientists to easily use and share research data collected across proprietary platforms.
The UK is shouldering the brunt of economic burden from coronary heart disease, according to new pan-European statistics from the British Heart Foundation and the European Heart Network.
Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.7 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 97.6 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 88.6 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 84.8 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.5 | 97.3 |
| Patients who got timely treatment for shortness of breath | 99.5 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 94.3 | 93.3 |
News Archive
Orchard Therapeutics, a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the opening of a second facility for technical operations in the San Francisco Bay Area.
The Federation of State Medical Boards approved a model telehealth policy this weekend that's made some providers of these services happy and others, well, not so much, because of its emphasis on using video rather than audio technology for a first patient visit (Conn, 4/28).
The world's leading mass spectrometer manufacturers have agreed to license technology that enabled University of Southern California (USC) researchers to develop software that, for the first time, allows scientists to easily use and share research data collected across proprietary platforms.
The UK is shouldering the brunt of economic burden from coronary heart disease, according to new pan-European statistics from the British Heart Foundation and the European Heart Network.
Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.
› Verified 5 days ago
| Home Health Aides | 21 |
| Counselors | 3 |
| Homemakers | 21 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 4 |
| Physicians | 1 |
| Registered Nurses | 18 |
| Other Personnel | 7 |
| Total Employees | 77 |
|---|
News Archive
Orchard Therapeutics, a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the opening of a second facility for technical operations in the San Francisco Bay Area.
The Federation of State Medical Boards approved a model telehealth policy this weekend that's made some providers of these services happy and others, well, not so much, because of its emphasis on using video rather than audio technology for a first patient visit (Conn, 4/28).
The world's leading mass spectrometer manufacturers have agreed to license technology that enabled University of Southern California (USC) researchers to develop software that, for the first time, allows scientists to easily use and share research data collected across proprietary platforms.
The UK is shouldering the brunt of economic burden from coronary heart disease, according to new pan-European statistics from the British Heart Foundation and the European Heart Network.
Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.
› Verified 5 days ago
| Counselors | 4 |
| Others | 6 |
| Total Volunteers | 10 |
|---|
News Archive
Orchard Therapeutics, a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the opening of a second facility for technical operations in the San Francisco Bay Area.
The Federation of State Medical Boards approved a model telehealth policy this weekend that's made some providers of these services happy and others, well, not so much, because of its emphasis on using video rather than audio technology for a first patient visit (Conn, 4/28).
The world's leading mass spectrometer manufacturers have agreed to license technology that enabled University of Southern California (USC) researchers to develop software that, for the first time, allows scientists to easily use and share research data collected across proprietary platforms.
The UK is shouldering the brunt of economic burden from coronary heart disease, according to new pan-European statistics from the British Heart Foundation and the European Heart Network.
Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.
› Verified 5 days ago
| Harbor Grace Hospice, Inc Location: 500 Lanier Avenue West, Suite 401, Fayetteville, Georgia, 30214 Phone: (678) 962-5850 |
| Doctors Hospice Of Georgia Location: 1008 Highway 54, Fayetteville, Georgia, 30214 Phone: (678) 962-5850 |
| Compassus-fayetteville Location: 145 Howard Lane, Fayetteville, Georgia, 30215 Phone: (678) 962-5850 |
| Precious Hospice Location: 105 Habersham Drive, Suite D, Fayetteville, Georgia, 30214 Phone: (678) 962-5850 |